Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: Results of a prospective European Prostate Cancer Detection Study

Journal of Urology

Volumn 166, Issue 3, 2001, Pages 856-860

  Djavan, Bob ^b   Waldert, Matthias ^b   Zlotta, Alexandre ^b   Dobronski, Piotr ^b   Seitz, Christian ^b   Remzi, Mesut ^b   Borkowski, Andrzej ^b   Schulman, Claude ^b   Marberger, Michael ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Biopsy; Morbidity; Prostate; Prostatic neoplasms; Reoperation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DYSURIA; EUROPE; FEVER; HEMATURIA; HEMOSPERMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEEDLE BIOPSY; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; RECTUM HEMORRHAGE; SAFETY; SEPSIS; SYNCOPE; TRANSRECTAL ULTRASONOGRAPHY; URINARY TRACT INFECTION; URINE RETENTION;

EID: 0034879729     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65851-X     Document Type: Article

References (35)

1. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate
2. Detection of non-palpable prostate cancer. A mathematical and laboratory model
3. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: A retrospective study
4. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer
5. Clinical application of transrectal ultrasonography and prostate specific antigen in the search of prostate cancer
6. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate
7. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen
8. The ability of systematic transrectal ultrasound guided biopsy to detect prostate cancer in men with the clinical diagnosis of benign prostatic hyperplasia
9. Transrectal needle method for biopsy of the prostate: Review of 90 cases
10. Transrectal biopsy of the prostate and bacteraemia
11. The problem of infection after prostatic biopsy: The case for the transperineal approach
12. Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy
13. Complications following combined transrectal aspiration and core biopsy of the prostate
14. The clinical usefulness of prostate specific antigen: Update 1994
15. Prostate-specific antigen: Critical issues
16. Clinical use of prostate specific antigen in patients with prostate cancer
17. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate
18. Optimal predictors of prostate cancer on repeat prostate biopsy: A prospective study of 1,051 men
19. Prostate specific antigen density of the transition zone for early detection of prostate cancer
20. PSA, PSA density, PSA density of transition zone, free/total PSA ratio and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng./mL
21. Patient tolerance of transrectal ultrasound-guided biopsy of the prostate
22. Multiple transrectal ultrasound-guided prostatic biopsies-true morbidity and patient acceptance
23. Side effects and patient acceptability of transrectal biopsy of the prostate
24. Risks and complications of transrectal ultrasound guided prostate needle biopsy: A prospective study and review of the literature
25. Urinary contamination as a result of transrectal biopsy of the prostate
26. Urinary tract infection following trans-rectal biopsy of the prostate
27. Prophylaxis against systemic infection after transrectal biopsy for suspected prostatic carcinoma
28. Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination
29. Transrectal ultrasound examination of the prostate: Complications and acceptance by patients
30. Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy
31. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: Evaluation of complication rates and risk factors within a population-based screening program
32. Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases
33. Determinants of complications after multiple transrectal core biopsies of the prostate
34. Infection after transrectal core biopsies of the prostate-risk factors and antibiotic prophylaxis
35. Transrectal biopsy of the prostate guided with transrectal US: Longitudinal and multiplanar scanning